ArticleFrontiers in oncology2021

Real-World Data on Outcomes in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Abiraterone or Enzalutamide: A Regional Experience.

Rachel Raju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.